Using biomarkers from patients’ tumors in clinical trials may not be as reliable as genetic variation in determining who will benefit most from particular drug treatments. For example, the protein levels detected in a test may differ based the part of a tumor from which a biopsy was obtained and the extent of a cancer’s […]
A paper published this month estimated that each year in the US about $28.2 billion, or half of the total spending on preclinical research, is used for preclinical studies that are not reproducible. “[T]he existence and propagation of one or more errors, flaws, inadequacies or omissions . . . that prevent replication of results” were […]
Expanding Markets Lift Affymetrix Q1 Sales Affymetrix first quarter sales grew 6.9%, 9% excluding currency, to $88.7 million. The negative impact from currency was partially reduced by hedging gains of $2.2 million. Product sales grew 7.7% to $79.4 million. Consumables sales grew 9.4%, and Instruments sales fell 23.5% to account for 86% and 3% of […]
The American Society of Mass Spectrometry (ASMS) held its 63rd annual conference from May 31 to June 4 at the downtown convention center in St. Louis, Missouri. Attendance totaled 6,101, falling 8.9% from last year (see IBO 6/30/14). MS companies at the conference focused on total-package solutions for research needs, unlike in previous years, when […]
Dynamic mechanical analysis (DMA) is a technique in materials characterization that measures the response of a material to a mechanical force. An applied mechanical force provides a stress on the material, and the material’s resulting reaction, or strain, can be quantified. A simple example is the compressive strain equivalent to the relative change in length […]
Bad Timing for Agilent Agilent Technologies fiscal second quarter sales ending April 30 contracted 2.5% to $963 million due to stronger-than-expected currency headwinds and divested product lines. In addition, timing of orders and shipping delays from the new Americas logistics center negatively impacted revenue growth by $30 million, or 3.0% of revenue growth. In spite […]
Sales for the IBO Analytical Instrument Index, which is comprised primarily of broad-based global analytical instrument businesses, declined 2.2% to $3,578 million. Excluding currency headwinds of 4.4%, Index sales grew 2.2%, driven by sales of LC and LC/MS, as well as demand from pharmaceutical and biopharma customers for Agilent and Waters. Demand for materials characterization […]
First quarter IBO Life Science Index sales advanced 6.3%, 7.1% excluding currency to $3,110 million, primarily due to Il-lumina’s strong sequencing revenues. Excluding Illumina, Index sales grew 2.7% or 2.8% on a currency-neutral basis. Overall, pharmaceutical and biopharma sales were strong for a majority of companies in the Index, especially for bioprouction within Thermo’s Life […]
Company Announcements In March, ImmunoReagents announced a strategic alliance to market ProteoVec’s PV-Pure Ig microscale antibody purification kits for binding a wide range of recombinant monoclonal and human/animal-source polyclonal immune globulins. The product is based on chromatographic purification resin to which an advanced peptidomimetic ligand is affixed. In April, Pressure BioSciences entered into a collaboration […]
Company Announcements Full-year 2014 sales for Horizon Discovery climbed 79.1% to £11.9 million ($19.5 million) (see IBO 4/15/15). Sales benefit-ed from acquisitions, as well as demand for genome-editing services and molecular diagnostic reagent products. Products and Services revenues jumped 39.4% and 151.6% to make up 29% and 60% of sales, respectively. Sales for the Leveraged […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
